Kim Walpole is the head of Trials.ai by ZS. Her passion for solving problems along the clinical study value chain drives her to build teams that create products aligned with her mission to enable study sponsors to get life-saving treatments to patients faster.

Kim brings two decades of experience working with pharmaceutical companies, where she has gained a profound understanding of the complexities of clinical trials and the specific needs of sponsors, CROs and sites. She is dedicated to building AI-enabled products to digitize, automate and add intelligence to the clinical study ecosystem with the goal of accelerating time to market. Kim’s proven expertise in building high-tech product companies, combined with her strong background in organizational development, have earned her a reputation as a results-driven leader.

Kim’s work with companies like Pfizer, Merck, Wyeth Ayerst, Orbital Sciences and Homeland Security gives her a unique perspective on product, technology, leadership development, strategy and organizational growth.